Table 3.
Intercept |
Slope |
DI |
||||
---|---|---|---|---|---|---|
Time | Group * Time | Time | Group * Time | Time | Group * Time | |
IGI with IFI | 0.044 | 0.503 | 0.022 | 0.674 | 0.259 | 0.227 |
iAUC ratio with IFI | 0.025 | 0.357 | 0.010 | 0.581 | 0.158 | 0.159 |
Phase 1 with M/I | 0.025 | 0.037 | <0.001 | 0.047 | <0.001 | 0.599 |
Phase 2 with M/I | 0.169 | 0.095 | 0.432 | 0.086 | 0.003 | 0.982 |
Values in cells are P values. Evaluations were performed using log-transformed secretion and sensitivity terms and repeated-measures mixed modeling as described in methods. In each instance, a Group × Time interaction term was evaluated to determine whether observed effects differed by time and/or study treatment. Values achieving statistical significance are presented in boldface. DI, disposition index; iAUC ratio, incremental area under the curve for insulin divided by incremental area under the curve for glucose; IGI, insulinogenic index; IFI, inverse fasting insulin; M/I, clamp steady-state glucose disposal rate divided by steady-state insulin concentrations. Statistically significant values are presented in bold for convenience.